Cyclosporine A in Cardiac Arrest

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 796 participants.

Also called NCT01595958

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 796 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01595958
  • EudraCT 2009-015725-37
Main results
  • Effect of Cyclosporine in Nonshockable Out-of-Hospital Cardiac Arrest: The CYRUS Randomized Clinical Trial JAMA cardiology, 2016-08-01 DOI, PubMed 27433815

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01595958. Randomized; single masking; primary purpose treatment. Start 2010-06 (registry gives no type); primary completion 2013-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cyclosporine A in Cardiac Arrest
Acronym
CYRUS
Condition
Non Shockable Out of Hospital Cardiac Arrest
Intervention (Drug)
Cyclosporine A
Intervention (Procedure)
cardio-pulmonary resuscitation
Lead sponsor
Hospices Civils de Lyon (class: other)

Record details

Record id
cardio:ct-nct01595958
Content hash
8e06223f596e73ab19067dff16f0e4a94b6be3253b9b90040c61f21e38b42b51